 Double-blind comparison doxazosin enalapril patients mild moderate essential hypertension antihypertensive efficacy safety doxazosin enalapril general practice setting agents comparable significant reductions mean blood pressure relevant changes heart rate Side effects groups mild moderate continued treatment Doxazosin contrast significant reduction total serum cholesterol concentration reduction level triglycerides favorable increase high-density lipoprotein/total cholesterol ratio reduction calculated coronary heart disease risk doxazosin significant enalapril